# Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT

> **NCT06412510** · PHASE1,PHASE2 · RECRUITING · sponsor: **Case Comprehensive Cancer Center** · enrollment: 22 (estimated)

## Conditions studied

- Ovarian Cancer
- Epithelial Ovarian Cancer
- Pancreatic Adenocarcinoma

## Interventions

- **OTHER:** Prehabilitation

## Key facts

- **NCT ID:** NCT06412510
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-05
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06412510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06412510, "Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT06412510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*